Search - tctmd.com

Displaying 181 - 200 of 1071

Sort: Relevancy | Date

News Daily News

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Michael O'Riordan

November 17, 2022

News Conference News AHA 2022

Drug Preconditioning Before CABG, Valve Surgery Shows Promise: START

Todd Neale

November 14, 2022

News Conference News AHA 2022

‘Agnostic’ EHR Alerts Boost VTE Prophylaxis in Hospitals and Postdischarge

L.A. McKeown

November 11, 2022

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

L.A. McKeown

November 07, 2022

News Conference News AHA 2022

New Tool Assesses Risk in Acute HF Then Suggests Next Steps, Cutting Later Events

Yael L. Maxwell

November 07, 2022

News Daily News

Renal Function Affects Ticagrelor/Aspirin Impact on Recurrent Stroke: CHANCE-2

Yael L. Maxwell

November 03, 2022

News Daily News

New Biomarker-Based Risk Score Performs Well in ACS

Michael O'Riordan

October 25, 2022

News Daily News

Two RCTs Add Needed Evidence for Thrombectomy in Basilar Occlusion

L.A. McKeown

October 13, 2022

News Daily News

AI-ECG Strategy Identifies Patients at Risk for AF

Todd Neale

September 30, 2022

News Daily News

COVID-19: TCTMD’s Dispatch for September 26

Shelley Wood

September 26, 2022

Presentation TCT 2022

TCT 167: Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized…

Presenter: Jonas Haener

September 19, 2022

News Conference News TCT 2022

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

Yael L. Maxwell

September 19, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Conference News ESC 2022

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

Michael O'Riordan

August 29, 2022

News Conference News ESC 2022

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

Shelley Wood

August 28, 2022

News Conference News ESC 2022

DELIVER Results, Other Analyses Bolster SGLT2 Inhibitors Across HF Spectrum

Todd Neale

August 27, 2022

News Conference News ESC 2022

Old Drug Acetazolamide Offers New Tricks in Acute HF: ADVOR

L.A. McKeown

August 27, 2022

News Industry News

Robocath’s Joint Venture, Cathbot, Concludes First Clinical Study in China to Evaluate Robotic PCI Safety and Efficacy

July 20, 2022

News Daily News

PFO Closure in Adults Over 60 Safe, but Patient Selection Key

Yael L. Maxwell

July 01, 2022

Advertisement

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Drug Preconditioning Before CABG, Valve Surgery Shows Promise: START

‘Agnostic’ EHR Alerts Boost VTE Prophylaxis in Hospitals and Postdischarge

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

New Tool Assesses Risk in Acute HF Then Suggests Next Steps, Cutting Later Events

Renal Function Affects Ticagrelor/Aspirin Impact on Recurrent Stroke: CHANCE-2

New Biomarker-Based Risk Score Performs Well in ACS

Two RCTs Add Needed Evidence for Thrombectomy in Basilar Occlusion

AI-ECG Strategy Identifies Patients at Risk for AF

COVID-19: TCTMD’s Dispatch for September 26

TCT 167: Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized…

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

New Faces, New Formats, New Tech: What to Expect From TCT 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

DELIVER Results, Other Analyses Bolster SGLT2 Inhibitors Across HF Spectrum

Old Drug Acetazolamide Offers New Tricks in Acute HF: ADVOR

Robocath’s Joint Venture, Cathbot, Concludes First Clinical Study in China to Evaluate Robotic PCI Safety and Efficacy

PFO Closure in Adults Over 60 Safe, but Patient Selection Key

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content